SDH genes, encoding succinate dehydrogenase, act as tumour suppressor genes, linking mitochondrial dysfunction with tumourigenesis. Heterozygous germline mutations in SDHA, SDHB, SDHC, SDHD and in the assembly factor encoding gene SDHAF2 have all been shown to predispose to heritable endocrine neoplasias such as pheochromocytomas (PHEO) and paragangliomas (PGLs) called 'PHEO -PGL syndrome'. SDH genes mutations, in addition to deletions or truncations which are most likely pathogenic, often include missense substitutions which can be of uncertain significance. Unclassified missense substitutions may be difficult to interpret unless the cause -effect link between mutation and the disease is established by functional and in silico studies or by the familial segregation with the phenotype. Using the yeast model, here, we report functional investigations on several missense SDH mutations found in patients affected by pheochromocytomas or paragangliomas. The aim of this study was to evaluate whether and to which extent the yeast model may be useful for establishing the pathological significance of missense SDH mutations in humans. The results of our study demonstrate that the yeast is a good functional model to validate the pathogenic significance of SDHB missense mutations while, for missense mutations in SDHC and SDHD genes, the model can be informative only when the variation involves a conserved residue in a conserved domain.
INTRODUCTION
The mitochondrial succinate dehydrogenase (SDH or complex II) is a critical enzyme linking the tricarboxylic acid cycle (TCA) to the mitochondrial respiratory chain. SDH is an iron -sulphur flavoprotein located in the inner mitochondrial membrane and catalyzes the oxidation of succinate to fumarate and the reduction of ubiquinone to ubiquinol. It consists of four structurally and functionally different subunits all encoded by nuclear genes (SDHA, SDHB, SDHC and SDHD): the SDHA and SDHB subunits form the catalytic dimer on the matrix face of the inner mitochondrial membrane, while SDHC and SDHD subunits anchor the catalytic dimer to the membrane (1) . Despite the extensive knowledge on structural and catalytic properties of the complex, only recently the SDH-specific assembly factor, called SDHAF1, and the factor responsible for the SDHA flavination, namely SDHAF2, have been identified (2, 3) .
Genetic defects of individual components of SDH cause distinct human diseases. Whilst heterozygous mutations in SDH subunits B, C and D encoding genes predispose to heritable endocrine neoplasias such as pheochromocytomas (PHEO) and paragangliomas (PGLs) responsible for 'PHEO -PGL syndromes' (4 -8) , homozygous mutations in SDHA cause the * To whom correspondence should be addressed at: Department of Life Sciences, University of Parma, Parco Area delle Scienze 11/A, 43124 Parma, Italy. Tel: +39 0521905107; Fax: +39 0521905604; Email: paola.goffrini@unipr.it Leigh syndrome, an early onset encephalopathy (9 -12) . Nevertheless, recently heterozygous mutations in SDHA have been associated with the occurrence of PGL (13, 14) .
Mutations in SDHAF1 and SDHAF2 encoding genes also cause typical mitochondrial disease and cancer, respectively. In fact, mutations in SDHAF1 lead to infantile leukoencephalopathy (2) and mutations in SDHAF2 segregate with hereditary PGL (PGL2 syndrome) (3) . SDH-linked tumours frequently present a somatic inactivation of the wild-type allele, indicating that SDH are typical tumour suppressor genes (5, 6, 15) .
Genetic testing for mutations in these tumour susceptibility genes is now a common practice: regarding PGL and PHEO syndromes, a broad spectrum of mutations in SDHB, SDHC and SDHD has been reported (16) . In addition to mutations that are most likely the cause of the disease, such as deletions or truncations, missense substitutions of uncertain significance are often found at genetic screening (16) . Unclassified missense substitutions, in the absence of familial segregation with the phenotype, are difficult to interpret and their pathogenic significance needs to be established by functional and/or in silico studies.
Several studies have demonstrated that the yeast is a suitable in vivo model to validate the pathogenic significance of mutations in genes involved in mitochondrial diseases, thanks to the similarity of orthologous yeast versus human OXPHOS-related genes, and to the ability of the yeast to survive the loss of respiratory function and of mitochondrial DNA (mtDNA), provided that a fermentative carbon source is made available (17, 18) .
The functional consequences of SDH mutations on the enzymatic as well as the respiratory activity of complex II have been studied in yeast (19, 20) , taking advantage of the high conservation of SDH complex through evolution. As in humans, also in yeast SDH is encoded by four nuclear genes, SDH1 to SDH4, which have been isolated and characterized (1) .
Recently, to assess the pathogenic significance of a novel SDHB germline missense mutation diagnosed in a patient affected by a glomus tumour, we performed functional studies in yeast (21) .
We report here on the effects exerted on yeast by a set of SDHB, SDHC, SDHD missense mutations with seemingly different pathogenic potential as inferred by the literature on the basis of the amino acid conservation among the species and on the effects of the mutation on protein folding (PolyPhen).
RESULTS

Complementation studies in yeast of human SDHB mutant alleles
The SDHB mutations evaluated in this study are listed in Table 1 . On the basis of the high conservation of the iron-sulphur subunit during evolution (Supplementary Material, Fig. S1 ) and a 64% identity between human (hSDHB) and yeast proteins (ySDH2), in almost all the cases it was possible to construct sdh2 mutant alleles carrying substitutions at positions correspondent to hSDHB mutations found in patients. The only exception was serine 5 in hSDHB that is substituted by leucine in ySDH2 protein; in this case, we constructed two variants, the 'humanized wild-type allele' and the mutant allele (see Materials and Methods). To assess the contribution to human pathology of each SDHB missense mutation, the oxidative growth (OXPHOS phenotype), SDH activity, respiratory activity, sensitivity to oxidative stress and extended mtDNA mutability ('petite' phenotype) were tested in Dsdh2 yeast strains carrying different sdh2 mutant alleles (see Table 1 for details).
To test the possible effects of mutations on the mitochondrial function, we first determined the OXPHOS phenotype (Fig. 1A) . On fermentative carbon sources, all strains grew equally well as the wild-type strain; on the contrary, on non-fermentable culture media (ethanol) yeast mutant strains showed distinct differences in growth. None of the strains containing the mutant alleles yR40L, yC95Y, yC189W, yR210L and yR235S were able to grow, behaving like the deleted strain. The sdh2 mutant alleles yR40Q, yL59R, yK72E, yR84Q, yR170H and yR235C partially complemented the oxidative growth defect of the Dsdh2 strain, whereas yS5F, yI121V and yG253R mutants displayed an OXPHOS phenotype similar to that of the wild-type. We then studied the effect of the mutations on 'SDH enzyme activity'. The results, as reported in Fig. 1B , indicate that the SDH activity levels differed significantly among the different mutants, according to their OXPHOS phenotype. yR40L, yC95Y, yC189W, yR210L and yR235S mutants showed no detectable SDH activity; yR40Q, yL59R, yK72E, yR84Q, yR170H and yR235C mutants showed a significant decrease in enzyme activity (30 -60% residual activity), whereas yS5F, yI121V and yG253R mutants showed an enzyme activity not significantly different from that of the wild-type.
As depicted in Fig. 2A , the mutant alleles unable to complement Dsdh2 and devoid of any detectable SDH activity showed respiration reduced by 50%, in agreement with what was previously observed (21) . The mitochondrial cytochrome profile, registered in some of these mutants, showed a significant reduction of the cytochrome aa3 (Fig. 2B) . Mutants whose oxidative growth was unaffected or only partially affected displayed a normal respiratory activity ( Fig. 2A) , suggesting that a reduced SDH activity does not impair the electron flux through the respiratory chain.
To evaluate whether sdh2 mutations lead to an increased production of reactive oxygen species (ROS), we analysed the sensitivity of the different mutants to the free radical inducer menadione.
As shown in Fig. 3A , only those mutations causing a severe impairment of oxidative growth and SDH activity caused hypersensitivity to menadione. In two of these mutants, yC95Y and yC189W, ROS accumulation was measured by dihydrorhodamine staining; cells carrying sdh2 C95Y or sdh2 C189W mutant alleles showed an intense intracellular staining in at least 30% of the population, while in cells carrying the wild-type gene the fluorescence was present in ,10% (Fig. 3B) .
In a previous paper, we reported that in the sdh2 C184Y mutant the OXPHOS phenotype and ROS accumulation were associated with mtDNA instability, as evidenced by an increased frequency of cytoplasmic 'petite' mutants (21) . Therefore, we evaluated whether an increase of ROS was associated with mtDNA instability also in mutant alleles considered in this study. Yeast mtDNA instability caused by different SDH2 mutations was evaluated by measuring the frequency of cytoplasmic 'petite' mutants. The frequency of 'petite' increased 3-fold in the yR40L, yC95Y, yC189W, yR210L and yR235S sdh2 strains, whereas the frequency of 'petite' in the strains harbouring the sdh2 alleles yS5F, Human Molecular Genetics, 2013, Vol. 22, No. 4 805 yR40Q, yL59R, yK72E, yR84Q, yI121V yR170H, yR235C and yG253R was not statistically different from that of the wildtype (Fig. 4A ).
On the basis of the above reported results, we classified the phenotypes of the mutated yeast strains as unaffected (U), mildly impaired (M) or severely impaired (S) ( Table 1) .
We also evaluated nuclear point mutability, measured as the rate of Canavanine-resistant Can R mutants, in the Dsdh2 strain and in cells transformed with two pathological alleles, one severely (yC95Y) and one mildly (yR84Q) impaired. As depicted in Fig. 4B , both mutations and null mutation caused a significant increase of nuclear point mutability, approximately 6-to 10-folds, in comparison to the wild-type allele.
Complementation studies in yeast of human SDHC and SDHD mutant alleles At variance with the iron -sulphur subunit, the two dimer membrane proteins SDHC and SDHD show a low conservation among different taxa (Supplementary Material, Figs S2 and S3).
As shown in the alignments, which include sequences from mammals to bacteria, among the SDHC mutations considered and listed in Table 2 , two SDHC mutations (R50C and I58T) involve a conserved or semi-conserved residue (R50 is conserved in animals, fungi and some bacteria, but not in plants, and I58 is semi-conserved in eukaryotes, but not in bacteria), whereas M164L mutations involve an amino acid neither conserved in yeast nor in mammals.
SDHD mutations considered and listed in Table 2 affect either residues moderately to highly conserved through evolution (P81L, G106D, T112I and Y114C) or residues poorly conserved and falling in not conserved domains (G12S, H50R and P53L), with H50 and P53 residues being partially conserved only in vertebrates. Nevertheless also for non conserved mutations, we constructed the 'humanized mutant variants' as described in the Materials and Methods section.
Y114C is a founder mutation detected in a large series of Italian families affected by head and neck PGLs (22); so we would expect to observe a detrimental effect in yeast.
The plasmid containing SDH4 alleles equivalent to SDHD, G12S, P53L, P81L, G106D, T112I and Y114C, were transformed into the null sdh4 mutant and the oxidative growth phenotype was first evaluated. With the exception of SDH4 Y120C , the mutants failed to show a significant growth defect ( Fig. 5A and Table 2 ). When SDH (succinate-PMS/ DCPIP reductase activity) was measured, yT118I mutation showed a 50% reduced activity, whilst in the yY120C mutant the reduction of SDH activity was less evident (Fig. 5B) . In all mutants, respiration did not differ from that of the wild-type (data not shown). The inability of the yY120C mutant to grow on an oxidative carbon source associated with an almost normal SDH activity is not surprising, given that Tyr114 is essential for ubiquinone reductase activity but not for the succinate-PMS/DCPIP reductase activity (23) .
None of the SDHD mutations tested appeared significantly more sensitive to oxidative stress, or higher producer of ROS than the wild-type (data not shown). However, when the mutability of mtDNA was evaluated, an increased frequency of 'petite' mutants was observed in yY120C and yT118I compared with wild-type (Fig. 5C ).
The strains carrying the non-conserved SDHD variants were indistinguishable from wild-type regarding oxidative growth, SDH activity, oxygen consumption and mtDNA mutability (Table 2) , with the exception of the strain carrying yP58L mutation which showed a slight decrease in SDH activity.
We also evaluated the effect of SDHC missense mutations in yeast; sdh3 null mutant transformed with yR75C (hR50C), yI58T (hI58T) mutant alleles and with the'humanized mutant variant' M193L (hM164L) were able to grow on nonfermentable medium (Fig. 6A ). However, in the yR75C (hR50C) mutant, we found a significant decrease in SDH enzyme activity seen associated with a 3-fold increase in the frequency of 'petite' mutants ( Fig. 6B and C) without any increase in ROS production (data not shown). The higher 'petite' mutability observed in the sdh3 null mutant compared with that of sdh2 and sdh4 null mutants depends on the different strain used to study sdh3 mutations. The use of a different genetic background was necessary because in the strain BY4741, the sdh3 mutation is lethal. 
Bold are the most significant values. S, severe phenotype; M, mild; U, unaffected; C, conserved amino acid; PSIC:SD, position-specific independent counts: score difference. Based on the results obtained in yeast on oxidative growth and enzymatic activity, we classified mutations supposed to be pathological in SDH2, the human orthologue of SDHB, into three groups:
(i) mutations which severely affect the OXPHOS phenotype (S): the yR40L (hR46L), yC95Y (hC101Y), yC189W (hC196W), yR210L (hR217L) and yR235S (hR242S) mutant alleles were unable to rescue both respiratory growth ability and SDH enzyme activity of the null mutant, thus, behaving as a null allele; (ii) mildly impaired mutations (M): the mutant alleles yR40Q (hR46Q) yL59R (hL65R), yK72E (hK80E), yR84Q (hR90Q), yR170H (hR177H) and yR235C (hR242C) although able to partially rescue the oxidative growth of the Dsdh2 strain considerably affected SDH enzyme activity (50% residual activity) and (iii) mutations which have no effect (U): strains carrying yS5F (hS8F), yI12IV (hI127V) and yG253R (hG260R) variants displayed a phenotype indistinguishable from that of the wild-type. When, besides the OXPHOS growth and the enzymatic activity, other phenotypes were considered, such as respiration, sensitivity to menadione and mtDNA mutability, only yeast mutants classified as severely affected [yR40L (hR46L), yC95Y (hC101Y), yC189W (hC196W), yR210L (hR217L) and yR235S (hR242S)], showed an increase of mtDNA mutability and an increased sensitivity to oxidative stress, thus behaving as the null allele. The results obtained indicate that these variants, which are considered pathogenic in humans, are severely pathological in yeast. Interestingly, these mutants regard amino acids highly conserved from mammals to bacteria and four out of five of them have the highest position-specific independent count (PSIC) at PolyPhen.
Yeast mutants classified as mildly affected [yR40Q (hR46Q) yL59R (hL65R), yK72E (hK80E), yR84Q (hR90Q), yR170H (hR177H) and yR235C (hR242G)] showed no increase in mtDNA mutability nor an increased sensitivity to oxidative stress. These mutations are also considered pathogenic in humans. All of them affect conserved amino acids and 4 out of 6 have a PSIC value of ,1.1 which is the lower limit for a variant to be considered probably damaging at PolyPhen.
When nuclear mutability of one of these mild mutations was analysed, a higher mutation frequency was observed, suggesting that these mutations should be considered pathological also in yeast although they only partially reduce SDH activity. Moreover, the results recently obtained by Rapizzi et al.(24) , that all SDH-mutated patients showed a decrease in SDH activity support our conclusion that an impaired SDH activity in yeast should be considered a good predicting factor of pathogenicity in humans.
Of the three residues whose substitutions do not affect the yeast phenotype, S8, which is poorly conserved through evolution, is a polymorphism (25) , and G260, although conserved between the humans and the yeast is barely conserved between animals and other eukaryotes and prokaryotes, suggesting that a substitution can be tolerated. Residue I127 is semiconserved in all kingdoms, suggesting that the substitution with the hydrophobic residue valine can be tolerated. Moreover, these three variants are associated with the lowest PSIC values. Thus, this analysis in yeast suggests that both the hI127V and hG260R are unlikely to be the sole cause of the disease.
The study of the effect of human mutations in the two genes encoding the dimer membrane subunits was more complicated because of the low conservation of the two proteins between different kingdoms. Indeed, several human mutations involve non-conserved residues in non-conserved domains in yeast.
Among the SDHD variants, hG12S, hH50R, hP53L and hP81L and hG106D are not pathological for the yeast. 
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Human Molecular Genetics, 2013, Vol. 22, No. 4 hG12S and hH50R are considered a polymorphism (26) as also suggested by the evolutionary analysis, which shows that G12 and H50 are poorly conserved among different animal phyla, while hP53L and hP81L are well-recognized pathogenic mutations. Whether the absence of the phenotype of these variants reflects their neutrality also in humans or depends on the low conservation of the region or of the residue itself remains an open question. The high conservation of proline 81 in the animal kingdom but not in the lower eukaryote or in bacteria and the high conservation of proline 53 only in vertebrates and casually in Saccharomyces cerevisiae suggest that the conservation within the animal kingdom or the vertebrate phylum has a good predictive value of pathogenicity. Although hG106 is rather conserved during evolution, a glutamate residue is present at the corresponding position of S. cerevisiae and other fungi. Thus, substitution of this residue in yeast with aspartate, which possesses similar properties, could explain why strain harbouring this mutation is unaffected; again, the absence of the phenotype could be caused by a lack of conservation between the humans and the yeast. This observation also supports the possible pathogenic effect of the two mutations in SDHD hT112I and hY114C; the first residue is conserved in vertebrates and in most fungi and some bacteria, the second in both eukaryotes and prokaryotes.
These two mutations, though affecting the yeast phenotype, have different effects. yY120C (hY114C) determines a severe functional defect: oxidative growth inability associated with a slightly reduced succinate PMS/DCPIP reductase activity but with a complete loss of ubiquinone reductase activity (23) . In addition, this mutation is associated with a significantly increased mtDNA mutability. This result is consistent with the fact that Y114C is a founder mutation that causes susceptibility to tumours in humans (22) . The yT118I (hT112I) mutation does not affect the oxidative growth, but affects the SDH enzyme activity that is reduced by 50%, and increases the mtDNA mutability. The results in yeast suggest that the mutation may cause susceptibility to tumours in humans.
Regarding SDHC mutations, hR50C (yR75C), but not hI58T (yI83T) and hM164L (yM193L), seems to be detrimental in yeast displaying a significant reduction of SDH activity, associated with a relevant increase of the frequency of 'petite' 
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mutants. Whereas R50 is conserved in most eukaryotes and prokaryotes, but not in plants, I58 is semi-conserved in eukaryotes, but not in bacteria and M164 is not conserved not only in yeast but also in mammals, suggesting that in the case of SDH3 conservation within the animal kingdom, could have a good predictive value of the pathogenicity of the mutation. The comparative analysis of our data leads to a rather interesting suggestion: the increase of mtDNA mutability was determined by several mutations in all three SDH subunits B, C and D. However, mtDNA mutability resulting from mutations of the B subunit was observed only when the SDH activity was completely abolished whereas, the mitochondrial mutability caused by SDHC and SDHD mutations was also observed when SDH enzyme activity was only partially reduced. In addition, the mutability of mtDNA caused by mutations in SDHB was always associated with an increase of ROS, whereas the increase of mtDNA mutability caused by mutations in anchor subunits SDHC and SDHD was not associated with an increase of ROS. Why SDHC and SDHD mutations result in mtDNA mutability even when SDH activity is not abolished and ROS production is not increased? The detrimental effect of mutations in these subunits might result from an alteration of inner mitochondrial membrane where SDHC and SDHD are embedded suggesting for these subunits a role in structural preservation of the mitochondrial membrane, which could in turn control mtDNA maintenance and stability. mtDNA mutations and/or insertions/deletions have been observed in many types of human cancers (27) , although the functional role of the various mitochondrial mutations in initiation and/or progression of cancer is still unclear. Whether the increased mtDNA mutability plays a role in the development of PGL syndromes in humans cannot be evaluated with a unicellular model as the yeast but deserves further experiments in human SDH-mutated tumour tissues. It is worth mentioning that recently Chen and co-authors reported that mitochondrial genome instability leads to tumourigenesis in mice (28) .
Overall, the results of our study aimed at validating the yeast as a model to predict the pathological significance of mutations in the SDH complex subunits, led us to two major conclusions.
When evaluating SDHC and SDHD subunits, which have a much less conserved sequence, the yeast model seems suitable to assess the pathogenic potential of new missense mutations if the functional assay is combined with the analysis of the residues conservation through evolution.
This analysis suggests that the conservation within the animal kingdom, or even only within the phylum vertebrate, is a good index of the substitution's pathogenic potential, independently of the conservation in other kingdom.
When the conservation also extends to prokaryotes, such as for the residue Y114 in SDHD, a severe phenotype is expected, as actually observed in yeast.
Theoretically, the expression in yeast of SDHC and SDHD human mutant alleles and the complementation tests in sdh3 and sdh4 null mutants would represent an excellent solution for validating the tests, but unfortunately, the human wild-type cDNAs are not able to complement the corresponding yeast mutations (our unpublished results). The great difference that exists between the yeast and human proteins does not allow to validate with certainty a mutation as suggested by the SDHD mutation hI58T (yI83T) which affects a conserved residue and results pathological in humans but not in yeast.
Conversely, our study demonstrates that in the case of SDHB, the yeast offers a suitable and good functional model to test the pathogenic potential of novel missense SDHB mutations. Moreover, an analysis of the conservation throughout evolution, in particular between animals and other eukaryotic kingdoms, and among eukaryotes and prokaryotes, may offer additional information to the functional test to establish the pathogenicity of the mutation.
MATERIALS AND METHODS
Yeast strains and culture condition
Yeast strains used were S. cerevisiae strain BY4741 (MATa; his3D1 leu2D0 met15D0 ura3D0) and its isogenic strains sdh2:kanMX4 and sdh4:kanMX4; strain W303-1B (Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100) (29) was used for the construction of a null Dsdh3 mutant. SDH3 open reading frame was replaced by the Kan R deletion cassette (29) containing all amino acids and bases, except those required for plasmid maintenance. Various carbon sources were added at 2% (w/v) (Carlo Erba Reagents, Italy). Media were solidified with 20 g/l agar (ForMedium TM ). For the cytochromes absorption spectra, respiration and mitochondria extraction cells were grown to late-log phase in the YNB medium supplemented with 0.6% glucose. For the assay of sensitivity to menadione (SigmaAldrich, Seelze, Germany) on plates, the cells, grown to the mid-logarithmic phase in YNB+ glucose 1%, were diluted sequentially and spotted onto the plates containing 30 mM menadione. Canavanine (CAN) plates included YNB medium supplemented with 0.006% L-canavanine sulphate (Sigma), amino acids and bases necessary to complement the auxotrophy and 2% glucose.
Construction of yeast mutant alleles
Wild-type SDH3 and SDH4 genes plus 5 ′ and 3 ′ flanking regions were PCR amplified and cloned into the pFL38 centromeric plasmid (31) giving rise to pFL38-SDH3 and pFL-38SDH4 plasmids. The pFL38-SDH2 construct has been previously described (21) . These constructs were used as templates for generating the mutant alleles by site-directed mutagenesis using the QuikChange II Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). The modified primers used to generate mutated alleles are reported in Supplementary Material, Table S1 . Both wild-type and mutagenized inserts were sequence verified on both the strands.
When human mutations involved a conserved residue, the corresponding yeast SDH codon was directly mutated by sitedirected mutagenesis, thus obtaining the 'pathological' allele. 
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When the SDH-mutated residue was not conserved, prior to construct the mutant allele a 'humanized wild-type allele' was produced in which the amino acid present in the yeast SDH protein was replaced with the wild-type amino acid present in the equivalent position of the human protein. All the mutants alleles as well as 'humanized' alleles on the pFL38 centromeric plasmid were transformed into the Dsdh yeast mutants.
Respiration and cytochrome spectra
Differential spectra between the reduced and oxidized cells of a suspension of cells at 60 mg/ml (wet weight) were recorded at room temperature, using a Cary 219 spectrophotometer. Oxygen uptake was measured at 308C using a Clark-type oxygen electrode in a 1 ml stirred chamber containing 1 ml of air-saturated respiration buffer (0.1 M phthalate-KOH, pH 5.0), 10 mM glucose (Oxygraph System Hansatech Instruments England) starting the reaction with the addition of 20 mg of wet weight of cells as previously described (21) .
Isolation of mitochondria and enzyme assay
Mitochondria was prepared as previously described (32) . Protein concentration was determined by the method of Bradford (33), using the Bio-Rad protein assay following the manufacturer's instructions. The succinate dehydrogenase DCIP assay was performed as described by (34) with minor modifications (21) . Enzyme activity was measured spectrofotometrically at a standard temperature of 308C. Mitochondrial and nuclear mutability determination 'Petite' frequency was determined as described previously (21, 35) . The frequency was defined as the percentage of colonies showing the petite phenotype after a 5-day incubation at 288C. For each strain, at least 4000 clones were analysed.
Nuclear point mutability was evaluated by measuring the forward mutation to canavanine resistance as previously reported (36) , except that colonies were grown on YNB medium supplemented with 2% glucose. Mutation rates were calculated using the median values according to Lea and Coulson (37) by using the program FALCOR (38) . The rates are given as the mean of four independent experiments in each of which 10 independent colonies for each clone were tested.
Measurement of intracellular oxidation levels
The oxidant-sensitive probe dihydrorhodamine123 (Molecular Probes) was used to measure intracellular oxidation levels (39) . The cells cultured in YNB supplemented with 1% glucose were treated with dihydrorhodamine123 and visualized by fluorescence microscopy (excitation l at 505 nm, blue/emission l at 534 nm, green); each aliquot was treated with Calcolfluor White (M2R) (Blue) to evidence the cell wall in order to count total cells. For each strain, the number of stained cells over total cells in twenty fields was counted in order to calculate the percentage values.
Miscellaneous yeast methods
Transformation of the yeast strain was obtained using the lithium-acetate method (40) . Restriction-enzyme digestions, Escherichia coli transformation and plasmid extractions were performed using standard methods (41) .
Simulation for functional change in the coding region by a structure homology-based method (PolyPhen)
The analysis of the genomic variants in the coding region at the structural level is considered important for understanding the functional activity of the protein of interest. To this end, we used the server PolyPhen (42) .
We submitted the query in the FASTA form of protein sequence with the mutational position of the two amino acid variants. Sequence-based characterization of the substitution site, profile analysis of homologous sequences and mapping of the substitution site to a known protein's three-dimensional structure are the parameters taken into account by PolyPhen server to calculate the score. It calculates the PSIC score for each of the two variants, and then computes the difference between the PSIC scores. The higher the PSIC score difference, the higher the functional impact a particular amino acid substitution is likely to have.
